Status:
COMPLETED
Dementia With Lewy Bodies - Infinitome
Lead Sponsor:
HealthPartners Institute
Conditions:
Dementia With Lewy Bodies
Eligibility:
All Genders
40-90 years
Brief Summary
Dementia with Lewy bodies (DLB) is the second most common cause of dementia and is associated with parkinsonism, hallucinations, and cognitive fluctuations. Diagnosis is often either missed or delayed...
Detailed Description
Omniscient, a for-profit, Sydney, Australia-based company, created the cloud-based software Infinitome, a program that utilizes data from the Human Connectome Project (HCP) together with machine learn...
Eligibility Criteria
Inclusion
- Age 40-90 years
- Established DLB diagnosis
- Mini mental status exam (MMSE) \>15
Exclusion
- Other forms of dementia including, but not limited to Alzheimer's dementia, frontotemporal dementia, vascular dementia, normal pressure hydrocephalus (NPH), etc,
- Inability to tolerate brain function magnetic resonance imaging (fMRI)
- Risk of brain fMRI due to implants or metal.
Key Trial Info
Start Date :
April 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 19 2023
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT04773041
Start Date
April 27 2021
End Date
June 19 2023
Last Update
November 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HealthPartners Neuroscience Center
Saint Paul, Minnesota, United States, 55130